X0206 3/A 2013-02-28 2011-10-11 0 0000805928 AxoGen, Inc. AXGN 0001531332 Gold Mark Stephen 13859 PROGRESS BOULEVARD SUITE 100 ALACHUA FL 32615 1 0 0 0 Stock Option (right to buy) 0.27 2008-07-25 2017-07-25 Common Stock 3727 D Employee Stock Option (right to buy) 0.27 2012-02-24 2021-02-24 Common Stock 15019 D Stock Option (right to buy) 1.07 2012-09-29 2021-09-29 Common Stock 869 D All of these options have vested. Amended to correct mistake in option exercise price after appropriate application of conversion ratio as explained in footnotes. Pursuant to an Agreement and Plan of Merger, dated as of May 31, 2011, by and among LecTec Corporation ("LecTec"), Nerve Merger Sub Corp., a subsidiary of LecTec ("Merger Sub"), and AxoGen Corporation ("AC"), which the parties amended on June 30, 2011 and August 9, 2011 (as amended, the "Merger Agreement"), Merger Sub merged with and into AC, with AC continuing after the merger as the surviving corporation and a wholly owned subsidiary of LecTec (the "Merger"). The Merger was completed on September 30, 2011, and LecTec was renamed AxoGen, Inc. ("AxoGen"). In connection with the Merger, each share of AC common stock converted into 0.03727336 share of LecTec common stock at the effective time of the Merger. In connection with the Merger, each option to purchase shares of AC common stock was converted tor an option to purchase 0.03727336 of a share of AxoGen common stock. These options vest annually over three years beginning with the Exercisable Date reported herein. Corrected to remove Stock Options to purchase 5,964, 4,864 and 4,210 shares at $.25, $.25 and $1.00 per share, respectively, and provide correct Stock Option. /s/ Dr. Mark S. Gold 2013-02-28